Welcome back to the Gens & Associates Podcast! In today's special episode, Host Katherine Yang-Iott is joined by Steve Gens and Greg Brolund to share early insights from the 2026 Regulatory Operational Excellence & World Class RIM Study. 

They highlight some of the most compelling trends from this year’s data, including steady RIM performance gains, expanding regulatory remits, rising interest in AI and automation, and the debut of the new Future Readiness Indicator.

In today’s episode, Steve Gens sits down with Rainer Schwarz, CEO of KlearDoc and Executive Advisor, to talk about two decades of regulatory software innovation and the rise of AI in the space. In this episode they explore early NLP‑driven text extraction, today’s LLM‑powered review automation, and Rainer’s staged vision for AI adoption across regulatory.

Listen now on your favorite podcast platform or on our website: https://gens-associates.com/gens-associates-podcast/

Want to hear more from Rainer? Connect with him on LinkedIn: https://www.linkedin.com/in/rainerschwarz010371/

In this episode, host Steve Gens is joined by Omar Serang (EVP and GM of DNAnexus) to explore the evolution of trusted regulatory spaces. The conversation covers PrecisionFDA, Project PRISM, protocol digitalization, and the emerging shift toward faster, more collaborative global regulatory processes.

Learn more about DNAnexus through their website: https://www.dnanexus.com/

In today’s episode, host Steve Gens is joined by Dominique Lagrave (Chief Regulatory Officer, Accumulus Technologies) to look at the future of regulatory collaboration — from one‑to‑many submissions to one‑click connectivity between sponsors and agencies. Join us for this insightful discussion on Regulatory Operations and the exciting future for Accumulus Technologies!

To learn more about Accumulus, reach out at [email protected] — or visit their website here: https://accumulustechnologies.com

In this special episode, host Steve Gens sits down with Remco Munnik, founder of Arcana, to explore the story behind the company’s creation and its guiding mission. As Arcana takes its first steps, Remco shares the aspirations and early plans that will shape its journey ahead.

In todays episode, host Steve Gens sits down with Ari Caroline, Co-Founder and Chief Strategy Officer of Weave, to explore how generative AI and platform thinking are reshaping the regulatory landscape. Ari shares Weave’s origin story, the metaphor behind its name, and how the company is building a “superhighway” for regulatory content generation. 

If you'd like to get to know Weave more, please visit their website at: https://www.weave.bio/

In todays episode, host Steve Gens welcomes back Toban Zolman (Founder and CEO of Kivo) for a founder to founder discussion on Kivo's rapid growth, why sponsors and CROs are embracing the platform, and how tectonic shifts, like AI, are reshaping R&D. They explore the tipping point for AI adoption, emerging trends in Biotechs, and Kivo's unique relationship with the community. 

To learn more about Kivo’s unified platform for regulatory, quality, and clinical operations, visit kivo.io or follow them on LinkedIn.

In today’s episode, Host Steve Gens sits down with ArisGlobal's Renato Rjavec (VP of Product Management, Regulatory). Together, they discuss ArisGlobal’s adoption of advanced technologies, the NavaX platform, and the next leaps for ArisGlobal in the near future.

You can learn more about ArisGlobal and their NavaX platform by visiting: https://www.arisglobal.com

In this episode, host Steve Gens sits down with Anita Modi, Co-Founder and CEO of Peer AI, for an insightful and forward-looking conversation on the future of AI enhanced authoring. They explore Peer’s founding story, early momentum, benefits of Agentic AI, and what the authoring environment could look like by 2030 — plus what’s ahead for Peer in the coming years!

You can find more about Peer AI by visiting their website at: https://getpeer.ai

In today’s episode, host Steve Gens is joined by Kevin Morgan (Chief Growth Officer of Glemser). Together, they discuss Glemser’s current focus, differentiating in the clinical space, and what to expect from Glemser in the coming years.

Enrollment is official open for the Regulatory Operational Excellence & World Class RIM(SM) Study! But it’s not too late, rolling enrollment will continue through September. Don’t miss your chance to participate in the survey built for all of Regulatory Life Science industry.

Make your mark and see how you compare to your peers: https://gens-associates.com/world-class-rim-research/